Vaccinia virus subverts xenophagy through phosphorylation and nuclear targeting of p62.


Journal

The Journal of cell biology
ISSN: 1540-8140
Titre abrégé: J Cell Biol
Pays: United States
ID NLM: 0375356

Informations de publication

Date de publication:
03 Jun 2024
Historique:
received: 27 04 2021
revised: 13 11 2023
accepted: 12 02 2024
medline: 6 5 2024
pubmed: 6 5 2024
entrez: 6 5 2024
Statut: ppublish

Résumé

Autophagy is an essential degradation program required for cell homeostasis. Among its functions is the engulfment and destruction of cytosolic pathogens, termed xenophagy. Not surprisingly, many pathogens use various strategies to circumvent or co-opt autophagic degradation. For poxviruses, it is known that infection activates autophagy, which however is not required for successful replication. Even though these complex viruses replicate exclusively in the cytoplasm, autophagy-mediated control of poxvirus infection has not been extensively explored. Using the prototypic poxvirus, vaccinia virus (VACV), we show that overexpression of the xenophagy receptors p62, NDP52, and Tax1Bp1 restricts poxvirus infection. While NDP52 and Tax1Bp1 were degraded, p62 initially targeted cytoplasmic virions before being shunted to the nucleus. Nuclear translocation of p62 was dependent upon p62 NLS2 and correlated with VACV kinase mediated phosphorylation of p62 T269/S272. This suggests that VACV targets p62 during the early stages of infection to avoid destruction and further implies that poxviruses exhibit multi-layered control of autophagy to facilitate cytoplasmic replication.

Identifiants

pubmed: 38709216
pii: 276731
doi: 10.1083/jcb.202104129
pii:
doi:

Substances chimiques

CALCOCO2 protein, human 0
Nuclear Proteins 0
Sequestosome-1 Protein 0
SQSTM1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
Pays : United Kingdom
Organisme : European Research Council
ID : 649101-UbiProPox
Pays : International
Organisme : Wellcome Trust
ID : 217202/Z/19/Z
Pays : United Kingdom

Informations de copyright

© 2024 Krause et al.

Auteurs

Melanie Krause (M)

MRC Laboratory for Molecular Cell Biology, University College London , London, UK.

Jerzy Samolej (J)

MRC Laboratory for Molecular Cell Biology, University College London , London, UK.
Institute of Microbiology and Infection, School of Biosciences, University of Birmingham , Birmingham, UK.

Artur Yakimovich (A)

MRC Laboratory for Molecular Cell Biology, University College London , London, UK.

Janos Kriston-Vizi (J)

MRC Laboratory for Molecular Cell Biology, University College London , London, UK.

Moona Huttunen (M)

MRC Laboratory for Molecular Cell Biology, University College London , London, UK.
Institute of Microbiology and Infection, School of Biosciences, University of Birmingham , Birmingham, UK.

Samuel Lara-Reyna (S)

Institute of Microbiology and Infection, School of Biosciences, University of Birmingham , Birmingham, UK.

Eva-Maria Frickel (EM)

Institute of Microbiology and Infection, School of Biosciences, University of Birmingham , Birmingham, UK.

Jason Mercer (J)

MRC Laboratory for Molecular Cell Biology, University College London , London, UK.
Institute of Microbiology and Infection, School of Biosciences, University of Birmingham , Birmingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH